| Literature DB >> 34071628 |
Ángel Romero-Martínez1, Mari-Carmen Blanco-Gandía2, Marta Rodriguez-Arias1, Marisol Lila3, Luis Moya-Albiol1.
Abstract
BACKGROUND: Only a few studies have paid attention to the ability of perpetrators of intimate partner violence (IPVAW) against women to cope with acute stress, including hormonal parameters. In fact, previous studies assessed how salivary testosterone (Tsal) and cortisol (Csal) changed after coping with an acute emotional stressor (directly related to IPVAW), and they concluded that an imbalance between the two hormones might be characteristic of these men. Nevertheless, they neglected to examine the role of other hormones, such as salivary oxytocin (OXsal), which also seemed to play an important role in behavioral regulation, and whether this response could be generalized to other types of stress not directly related to IPVAW.Entities:
Keywords: acute stress; cortisol; intimate partner violence; oxytocin; testosterone
Mesh:
Substances:
Year: 2021 PMID: 34071628 PMCID: PMC8198212 DOI: 10.3390/ijerph18115831
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Means (Standard Deviations), Percentages, and Means Comparisons for Anthropometric (age and body mass index) and Demographic Variables in All Groups.
| IPVAW Perpetrators | Controls | Significance | ||
|---|---|---|---|---|
| Age ( | 39.68 (10.24) | 41.43 (8.39) | −0.55 | 0.588 |
| Body mass index | 24.66 (3.73) | 27.25 (6.86) | −1.41 | 0.165 |
| Marital status (%) | ||||
| Married | 11 | 25 | 1.28 | 0.351 |
| Single, divorced or separated | 89 | 75 | ||
| Level of education (%) | ||||
| Primary/lower secondary | 79 | 56 | 3.38 | 0.185 |
| Upper secondary/vocational training | 21 | 31 | ||
| University | - | 13 | ||
| Employment status (%) | ||||
| Employed | 84 | 63 | 2.14 | 0.245 |
| Unemployed | 16 | 37 | ||
| Number of offspring (M, SD) | 1.21 (1.22) | 0.57 (0.63) | 1.91 | 0.065 |
Figure 1Csal (a), T/C ratio (b), and (c) Oxsal levels for IPVAW and control groups. Note. Csal: Salivary Cortisol; Csal/Tsal ratio; Salivary Cortisol and Testosterone ratio; IPVAW: Intimate Partner Violence; OXsal: Salivary Oxytocin. * p < 0.05.
Means and Standard Error of the Mean for Hormones in Each Group.
| IPVAW Perpetrators | Controls | Mean Difference | CI (95%) | F ANOVA | Significance | Partial Eta Squared (ηp2) | |
|---|---|---|---|---|---|---|---|
| Tsal (pg/mL) | |||||||
| Baseline | 141.58 (22.04) | 131.81 (20.51) | 9.77 | −52 to 71 | 0.58 | 0.60 | 0.02 |
| Preparatory | 107.58 (0.007) | 127.81 (19.67) | −20.23 | −0.75 to 34 | |||
| Post-task | 137.22 (16.74) | 126.50 (17.85) | 10.72 | −39 to 60 | |||
| Post-task +20 | 122.57 (15.90) | 131.37 (22.23) | −8.79 | −64 to 47 | |||
| Csal (pg/mL) | |||||||
| Baseline | 2.722 (297.12) | 2.848 (311.93) | −126.64 | −1005 to 752 | 2.71 | 0.05 | 0.08 |
| Preparatory | 3.108 (372.22) | 2.947 (345.55) | 161.18 | −886 to 1209 | |||
| Post-task | 2.557 (274.58) | 3.910 (492.50) * | −1352.73 | −2516 to −188.75 | |||
| Post-task +20 | 2.855 (325.36) | 3.446 (433.33) | −591.87 | −1700 to 516 | |||
| OXsal (log-transformed) | |||||||
| Baseline | 4.67 (0.100) | 4.62 (0.162) | 0.05 | −0.32 to 0.42 | 0.99 | 0.40 | 0.03 |
| Preparatory | 4.86 (0.096) | 4.51 (0.184) | 0.35 | −0.05 to 0.76 | |||
| Post-task | 4.73 (0.132) | 4.22 (0.179) | 0.50 | 0.04 to 0.96 | |||
| Post-task +20 | 4.72 (0.115) | 4.55 (0.238) | 0.17 | −0.38 to 0.72 | |||
| Tsal/Csal ratio | |||||||
| Baseline | 0.06 (0.009) | 0.05 (0.009) | 0.01 | −0.02 to 0.03 | 3.89 | 0.03 | 0.11 |
| Preparatory | 0.04 (0.005) | 0.05 (0.011) | −0.02 | −0.04 to 0.009 | |||
| Post-task | 0.08 (0.018) | 0.04 (0.006) * | 0.04 | 0.004 to 0.08 | |||
| Post-task +20 | 0.05 (0.008) | 0.04 (0.007) | 0.01 | −0.01 to 0.03 | |||
| Tsal/OXsal ratio | |||||||
| Baseline | 1.57 (0.325) | 1.52 (0.321) | 0.05 | −0.88 to 0.99 | 1.01 | 0.36 | 0.03 |
| Preparatory | 0.95 (0.213) | 2.52 (1.249) | −1.56 | −3.93 to 0.80 | |||
| Post-task | 1.31 (0.222) | 2.12 (0.629) | −0.81 | −2.10 to 0.49 | |||
| Post-task +20 | 1.19 (0.206) | 2.03 (0.755) | −0.84 | −2.49 to 0.81 | |||
| Csal/OXsal ratio | |||||||
| Baseline | 29.98 (6.618) | 34.85 (6.647) | −4.87 | −24 to 14 | 0.67 | 0.47 | 0.02 |
| Preparatory | 26.21 (4.254) | 58.28 (29.87) | −32 | −88 to 24 | |||
| Post-task | 28.39 (6.713) | 56.04 (11.140) | −27 | −53 to −2.10 | |||
| Post-task +20 | 30.39 (6.614) | 46.71 (12.488) | −16 | −43 to 10 | |||
Note. Csal: Salivary Cortisol; IPVAW: Intimate Personal Violence; OXsal: Salivary Oxytocin; Tsal: Salivary Testosterone. * p < 0.05.
Means and Standard Error of the Mean for Hormones and Psychological state variables in Each Group.
| IPVAW Perpetrators | Controls | Mean | CI (95%) | F ANOVA | Significance | Partial Eta Squared (ηp2) | |
|---|---|---|---|---|---|---|---|
| STAI-S | |||||||
| Baseline | 24.74 (1.08) | 23.94 (1.29) | 0.79 | −2.59 to 4.19 | 3.08 | 0.09 | 0.09 |
| Post-task | 24.21 (1.04) | 21.44 (1.39) | 2.77 | −0.70 to 6.25 | |||
| STAXI-2 | |||||||
| Baseline | 17.79 (2.38) | 15.31 (0.17) | 2.47 | −2.82 to 7.78 | 0.87 | 0.36 | 0.03 |
| Post-task | 15.31 (0.18) | 15.31 (0.19) | 0.003 | −0.62 to 0.63 | |||
| PANAS | |||||||
| Negative affect | |||||||
| Baseline | 12.68 (0.83) | 13.06 (0.71) | −0.37 | −2.65 to 1.89 | 0.04 | 0.83 | 0.00 |
| Post-task | 12.42 (0.63) | 13.06 (1.28) | −0.64 | −3.41 to 2.12 | |||
| Positive affect | |||||||
| Baseline | 30.84 (1.35) | 29.63 (1.54) | 1.22 | −2.93 to 5.37 | 1.77 | 0.19 | 0.05 |
| Post-task | 33.67 (3.09) | 27.94 (2.03) | 5.43 | −2.12 to 12.98 |
Note. IPVAW: Intimate Personal Violence against Women.
Relationships of hormonal variables (baseline and AUC) with psychological state assessment (baseline and change score) for IPVAW perpetrators and controls applying Bonferroni correction.
| STAI-S | STAI-S | STAXI-2 | STAXI-2 | PANAS | PANAS | PANAS | PANAS | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPVAW Controls | IPVAW Controls | IPVAW Controls | IPVAW Controls | IPVAW Controls | IPVAW Controls | IPVAW Controls | IPVAW Controls | |||||||||
| Tsal baseline | −0.346 | −0.592 | 0.262 | 0.121 | 0.275 | 0.002 | −0.236 | −0.106 | −0.126 | −0.307 | 0.168 | 0.054 | 0.162 | −0.342 | −0.166 | 0.087 |
| Tsal AUCi | 0.086 | 0.391 | 0.105 | −0.127 | −0.260 | −0.127 | 0.255 | 0.242 | 0.337 | 0.110 | −0.317 | 0.065 | −0.496 | 0.110 | 0.156 | 0.076 |
| Tsal AUCg | 0.157 | 0.386 | 0.105 | −0.221 | −0.209 | −0.227 | 0.211 | 0.229 | −0.335 | −0.007 | 0.384 | −0.104 | −0.444 | −0.158 | 0.122 | 0.257 |
| Csal baseline | 0.686 ** | −0.161 | −0.662 | 0.204 | −0.057 | −0.102 | −0.390 | −0.067 | −0.108 | −0.305 | −0.285 | 0.139 | 0.150 | −0.034 | −0.111 | −0.028 |
| Csal AUCi | 0.082 | 0.119 | 0.352 | 0.265 | −0.344 | −0.040 | 0.318 | 0.080 | 0.646 ** | 0.171 | −0.332 | 0.137 | −0.438 | 0.204 | 0.022 | 0.039 |
| Csal AUCg | 0.136 | 0.199 | 0.393 | 0.219 | −0.237 | −0.146 | 0.206 | 0.224 | 0.530 | 0.107 | −0.271 | 0.139 | −0.332 | 0.022 | 0.083 | 0.128 |
| OXsal baseline | −0.321 | −0.160 | −0.175 | −0.192 | −0.451 | −0.603 | 0.435 | 0.424 | −0.054 | 0.253 | 0.237 | −0.046 | −0.290 | −0.076 | 0.221 | −0.172 |
| OXsal AUCi | 0.382 | 0.246 | 0.195 | 0.175 | 0.295 | 0.145 | −0.296 | −0.027 | 0.057 | 0.135 | −0.193 | 0.109 | 0.228 | 0.292 | −0.013 | 0.150 |
| OXsal AUCg | 0.326 | 0.236 | 0.208 | 0.099 | 0.186 | 0.004 | −0.185 | −0.027 | 0.190 | 0.070 | −0.088 | 0.111 | 0.118 | 0.333 | −0.165 | 0.062 |
| Tsal/Csal ratio baseline | −0.117 | −0.466 | 0.418 | −0.061 | −0.025 | 0.018 | 0.031 | −0.056 | 0.138 | −0.144 | 0.243 | −0.007 | −0.001 | −0.276 | −0.086 | 0.172 |
| Tsal/Csal ratio AUCi | −0.186 | −0.425 | 0.413 | 0.125 | 0.013 | 0.147 | −0.017 | −0.044 | 0.039 | −0.100 | 0.272 | 0.095 | 0.076 | −0.152 | −0.005 | 0.387 |
| Tsal/Csal ratio AUCg | −0.264 | −0.425 | 0.054 | −0.032 | 0.213 | 0.107 | −0.173 | 0.199 | −0.250 | 0.061 | 0.316 | −0.175 | −0.036 | −0.464 | −0.091 | 0.126 |
| Tsal/OXsal ratio baseline | −0.105 | −0.345 | 0.092 | 0.140 | 0.603 | 0.511 | −0.565 | −0.448 | −0.102 | 0.031 | 0.014 | 0.046 | 0.278 | −0.166 | −0.226 | 0.025 |
| Tsal/OXsal ratio AUCi | −0.546 | −0.367 | 0.400 | 0.258 | −0.052 | −0.054 | 0.118 | −0.009 | 0.209 | −0.153 | 0.010 | −0.131 | −0.275 | −0.071 | −0.212 | 0.112 |
| Tsal/OXsal ratio AUCg | −0.482 | −0.274 | 0.523 | 0.116 | −0.014 | −0.001 | 0.065 | −0.132 | 0.083 | −0.119 | −0.073 | −0.042 | −0.357 | −0.010 | −0.138 | 0.041 |
| Csal/OXsal ratio baseline | 0.172 | −0.061 | −0.325 | 0.174 | 0.868 ** | 0.420 | −0.849 ** | −0.418 | 0.442 | 0.006 | −0.246 | 0.067 | 0.253 | −0.035 | −0.153 | 0.032 |
| Csal/OXsal ratio AUCi | −0.028 | −0.284 | 0.268 | 0.260 | −0.084 | −0.058 | 0.098 | −0.054 | −0.085 | −0.160 | −0.451 | −0.084 | −0.392 | 0.024 | −0.200 | 0.093 |
| Csal/OXsal ratio AUCg | −0.127 | −0.197 | 0.147 | 0.244 | 0.183 | 0.135 | −0.171 | −0.287 | 0.050 | −0.043 | −0.162 | −0.039 | −0.184 | 0.118 | −0.138 | 0.067 |
Note. AUC: Area Under the Curve; Csal: Salivary Cortisol; IPVAW: Intimate Personal Violence Against Women; OXsal: Salivary Oxytocin; Tsal: Salivary Testosterone. ** p ≤ 0.001.